权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Targeting the GTP-bound state of oncogenic Ras proteins

靶向致癌 Ras 蛋白的 GTP 结合状态

基本信息

批准号：
10066639
负责人：
David Matthew Peacock
金额：
$ 6.53万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-08-01 至 2022-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10066639
关键词：
Active Sites Affinity Allosteric Site Binding Binding Sites Biochemical Biological Assay Biology Cell Proliferation Chemicals Chemistry Communities Cysteine Development Disulfides Faculty Family GTP Binding Guanosine Triphosphate Guanosine Triphosphate Phosphohydrolases Health Human Hydrolysis Impairment Kinetics Knowledge Lead Learning Lesion Libraries Literature Location Lysine Malignant Neoplasms Measures Mediating Medical Mentors Methodology Methods Monomeric GTP-Binding Proteins Mutate Mutation NMR Spectroscopy Nucleotides Oncogenes Oncogenic Organic Chemistry Pharmaceutical Preparations Phosphorylation Protein NMR Spectroscopy Proteins RAS genes RAS inhibition Ras Inhibitor Reaction Reading Research Research Proposals Scientist Signal Pathway Signal Transduction Signaling Protein Son of Sevenless Proteins Structure Synthesis Chemistry Techniques Therapeutic Training Work X-Ray Crystallography anticancer research biochemical tools career cell growth combinatorial combinatorial chemistry covalent bond design experience experimental study functional group improved inhibitor/antagonist instrumentation lipophilicity mutant novel therapeutics professor programs protein expression protein purification raf Kinases ras Proteins small molecule small molecule inhibitor therapeutic target tumor

项目摘要

RESEARCH SUMMARY/ABSTRACT Mutations in Ras genes are the most common activators of cancer in humans, and effective inhibitors of the GTPases they encode have been sought as potential cancer therapeutics. Despite extensive research in this field, Ras proteins remain among the most challenging targets in medical chemistry. Oncogenic mutations in Ras genes typically result in proteins locked in the “on” GTP-bound state, which binds its effectors Raf kinases and PI3K. Therefore, small molecules that target GTP-bound Ras proteins and disrupt interactions with effectors are expected to be promising cancer therapeutics. This proposal seeks to develop small molecule inhibitors of Ras(GTP) by targeting the recently discovered “switch II groove.” The strategy combines techniques from synthetic chemistry, combinatorial chemistry, and chemical biology to increase the non-covalent affinity of binders, evaluate them as inhibitors of Ras(GTP), and develop N- and H-Ras oncogene-selective inhibitors. This research strategy was designed to both leverage my existing knowledge of synthetic chemistry and train me in new chemical biology techniques. The experimental work will require me to learn protein expression and purification, protein NMR spectroscopy, and a range of biochemical assays to detect inhibition of Ras GTPases. By reading the relevant literature and discussing this project with experienced scientists, I will greatly improve my understanding of the protein signaling pathways involved in cell growth and proliferation which are mis- regulated in cancer. UCSF is an ideal location for me to receive training in chemical biology due to its wide range of experienced faculty, excellent instrumentation facilities, and connections with the wider chemical biology community. I intend to pursue an academic career applying organic chemistry to the improvement of human health; specifically, I wish to develop new synthetic methodology to enable the discovery of inhibitors for challenging and dynamic protein targets. My academic studies and graduate research have given me a strong background in organic chemistry and synthetic methods; however, my formal training in chemical biology is lacking. I chose to join Professor Shokat’s group at UCSF because I believe he is an ideal mentor to help me remedy that lack and better prepare me for an independent career.

研究总结/文摘